-
Mashup Score: 1Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients - 1 year(s) ago
MicroabstractWe analyzed vaccination rates and associated outcomes of patients with multiple myelom in the INSIGHT MM study. Influenza vaccination in the prior 2 years and pneumococcal vaccination in the prior 5 years impacted overall survival versus no vaccination. Additionally, deaths due to infections were lower among vaccinated versus non-vaccinated patients. Vaccination status should be…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2SOHO State-of-the-Art Updates and Next Questions: A Modern Approach to the Systemic Treatment of Advanced CTCL - 1 year(s) ago
The term cutaneous T-cell lymphoma (CTCL) is a general term for T-cell lymphomas that are found primarily in skin. The most common CTCL entities, mycosis fungoides and Sezary syndrome are incurable diseases with a plethora of conventional treatment options. In the past treatment options have been selected primarily according to stage. Given newer targeted therapies with varied response in…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
This study assessed treatment discontinuation patterns and reasons among chronic lymphocytic leukemia (CLL) patients initiating first-line (1L) and second line (2L) treatments in real-world settings.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation Therapies - 1 year(s) ago
Micro-AbstractThis study evaluated the epidemiology and infection risks in patients with multiple myeloma managed with second-generation therapies and monoclonal antibodies. Clinical records of 148 patients with multiple myelomawere reviewed to capture demographics, treatments, infection episodes, and outcomes. Viral infections now constitute the majority of infections, and a higher risk patient…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Vaccination in Multiple Myeloma: Review of Current Literature - 1 year(s) ago
Multiple myeloma is a cancer of the immune system. Infection is a major cause of morbidity and mortality in patients with multiple myeloma. Some of these infections are preventable by vaccines available to the general population. However, little is known about the clinical effectiveness of these vaccines in patients with multiple myeloma, and the cellular and humoral immune response to…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients - 1 year(s) ago
MicroabstractWe analyzed vaccination rates and associated outcomes of patients with multiple myelom in the INSIGHT MM study. Influenza vaccination in the prior 2 years and pneumococcal vaccination in the prior 5 years impacted overall survival versus no vaccination. Additionally, deaths due to infections were lower among vaccinated versus non-vaccinated patients. Vaccination status should be…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Micro-AbstractIn patients with newly diagnosed lymphoma, low bone mineral density (BMD) is common at diagnosis and worsens with therapy. Our randomized phase III trial demonstrates that 2 doses of zoledronic acid (ZA) and supplementation with calcium and vitamin D effectively prevent further bone loss.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients - 1 year(s) ago
MicroabstractWe analyzed vaccination rates and associated outcomes of patients with multiple myelom in the INSIGHT MM study. Influenza vaccination in the prior 2 years and pneumococcal vaccination in the prior 5 years impacted overall survival versus no vaccination. Additionally, deaths due to infections were lower among vaccinated versus non-vaccinated patients. Vaccination status should be…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
MicroabstractThe impact of sex as a biological variable on the clinical phenotype, genotype, and outcomes among patients with myelodysplastic syndromes (MDS) is not well characterized. We retrospectively reviewed the clinical and genomic data on male and female patients included in our institutional MDS database. Disease characteristics, mutations, and survival differed between men and women.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients - 1 year(s) ago
MicroabstractWe analyzed vaccination rates and associated outcomes of patients with multiple myelom in the INSIGHT MM study. Influenza vaccination in the prior 2 years and pneumococcal vaccination in the prior 5 years impacted overall survival versus no vaccination. Additionally, deaths due to infections were lower among vaccinated versus non-vaccinated patients. Vaccination status should be…
Categories: Hem/Oncs, Latest HeadlinesTweet
Rates of Influenza and Pneumococcal Vaccination and Correlation with Survival in Multiple Myeloma Patients [Dec 6, 2022] @mtmdphd et al. @AjaiChari CLML https://t.co/kUQeRmeiMt #NCT02761187 #mmsm #IDonc #ClinicalTrials #caxtx https://t.co/55K6wfvswJ